---
figid: PMC6315857__ncrna-04-00026-g001
figlink: /pmc/articles/PMC6315857/figure/ncrna-04-00026-f001/
number: Figure 1
caption: Transforming growth factor-β 1 (TGF-β1) mediates a signaling pathway in tissue
  fibrosis. The latent TGF-β binding proteins (LTBP) complex is cleaved by proteases
  to release the active TGF-β1 that binds to the extracellular domain of TGF-β receptor
  type II (TβRII). The activated TβRII then phosphorylates TGF-β receptor type I (TβRI)
  kinase, thus triggering downstream signaling via either or both of the canonical
  (Smads-dependent) and noncanonical (Smads-independent) pathways. In the canonical
  pathway, TβRI phosphorylates Smad2 and Smad3, and then these Smads bind with Smad4
  and this complex translocates into the nucleus. Meanwhile, TGF-β1 also activates
  Smad ubiquitin regulatory factor (Smurf) to degrade Smad7 to further enhance signaling.
  On the other hand, TGF-β1 can also induce profibrotic responses via a noncanonical
  pathway in a Smads-independent manner. TGF-β1 activates extracellular signal-regulated
  kinase (ERK) activation (Ras recruits Raf to the plasma membrane and leads to activation
  of ERK through mitogen-activated protein kinase (MEK)); c-Jun amino terminal kinase
  (JNK)/p38 activation JNK and p38 are at the tertiary layer of the mitogen-activated
  protein kinase (MAPK) pathway, in which they are activated by the MAP kinase kinases
  (MKKs), MKK4 and MKK3/6, respectively); Rho-like GTPases activation (the Rho-like
  GTPases include RhoA, Rac, and Cdc42); Phosphoinositide3-kinase/RAC-alpha serine/threonine-protein
  kinase (PI3K/AKT) activation (AKT is activated via PI3K, which then controls translational
  responses through mammalian target of rapamycin (mTOR)); induction of reactive oxygen
  species (ROS) (hypoxia-responsive element activity and hypoxia-inducible factor-1α
  expression by TGF-β1, then the p53 tumor suppressor can be induced). In addition,
  crosstalks may occur between TGF-β1/Smad and other pathways during tissue fibrosis.
pmcid: PMC6315857
papertitle: LncRNAs in TGF-β-Driven Tissue Fibrosis.
reftext: Patrick Ming-Kuen Tang, et al. Noncoding RNA. 2018 Dec;4(4):26.
pmc_ranked_result_index: '48232'
pathway_score: 0.9699147
filename: ncrna-04-00026-g001.jpg
figtitle: Transforming growth factorB 1 (TGFB1) mediates a signaling pathway in tissue
  fibrosis
year: '2018'
organisms: Homo sapiens
ndex: ba38a1e9-deb2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6315857__ncrna-04-00026-g001.html
  '@type': Dataset
  description: Transforming growth factor-β 1 (TGF-β1) mediates a signaling pathway
    in tissue fibrosis. The latent TGF-β binding proteins (LTBP) complex is cleaved
    by proteases to release the active TGF-β1 that binds to the extracellular domain
    of TGF-β receptor type II (TβRII). The activated TβRII then phosphorylates TGF-β
    receptor type I (TβRI) kinase, thus triggering downstream signaling via either
    or both of the canonical (Smads-dependent) and noncanonical (Smads-independent)
    pathways. In the canonical pathway, TβRI phosphorylates Smad2 and Smad3, and then
    these Smads bind with Smad4 and this complex translocates into the nucleus. Meanwhile,
    TGF-β1 also activates Smad ubiquitin regulatory factor (Smurf) to degrade Smad7
    to further enhance signaling. On the other hand, TGF-β1 can also induce profibrotic
    responses via a noncanonical pathway in a Smads-independent manner. TGF-β1 activates
    extracellular signal-regulated kinase (ERK) activation (Ras recruits Raf to the
    plasma membrane and leads to activation of ERK through mitogen-activated protein
    kinase (MEK)); c-Jun amino terminal kinase (JNK)/p38 activation JNK and p38 are
    at the tertiary layer of the mitogen-activated protein kinase (MAPK) pathway,
    in which they are activated by the MAP kinase kinases (MKKs), MKK4 and MKK3/6,
    respectively); Rho-like GTPases activation (the Rho-like GTPases include RhoA,
    Rac, and Cdc42); Phosphoinositide3-kinase/RAC-alpha serine/threonine-protein kinase
    (PI3K/AKT) activation (AKT is activated via PI3K, which then controls translational
    responses through mammalian target of rapamycin (mTOR)); induction of reactive
    oxygen species (ROS) (hypoxia-responsive element activity and hypoxia-inducible
    factor-1α expression by TGF-β1, then the p53 tumor suppressor can be induced).
    In addition, crosstalks may occur between TGF-β1/Smad and other pathways during
    tissue fibrosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TBL1XR1
  - ATM
  - PIK3CB
  - AKT2
  - AKT3
  - ATR
  - SMAD7
  - NR2C2
  - TGFB1
  - AKT1
  - PIK3CA
  - MAP2K2
  - MAP2K3
  - PIK3R4
  - MAP2K4
  - MTOR
  - MAPK11
  - MAP2K6
  - MAPK1
  - MAPK3
  - MAPK8
  - MAPK14
  - PIK3R5
  - NRAS
  - HRAS
  - RHOA
  - SMAD2
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - RAF1
  - MAPK13
  - MAPK12
  - TP53
  - PIK3R6
  - KRAS
  - MAPK10
  - MAP2K1
  - TRAF6
  - ARAF
  - SMAD3
  - SMAD4
  - MAPK9
  - TGFBR1
  - BRAF
  - Fibrosis
genes:
- word: dc42/Rag
  symbol: DC42
  source: hgnc_alias_symbol
  hgnc_symbol: TBL1XR1
  entrez: '79718'
- word: ATM/ATR
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ATM/ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: Smad7
  symbol: SMAD7
  source: hgnc_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: TGF-B1
  symbol: TGFB1
  source: hgnc_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MKK3/6
  symbol: MKK3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MKK4
  symbol: MKK4
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MKK3/6
  symbol: MKK6
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: Smad2
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: P53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Smad3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: TGFBRI
  symbol: TGFBR1
  source: hgnc_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
chemicals: []
diseases:
- word: Fibrosis
  source: MESH
  identifier: D005355
---
